T9623 |
RORγt inverse agonist 13
|
2170477-75-3
|
98%
|
|
RORγt inverse agonist 13 (Compound 3i) is a potent, orally active and selective RORγt inverse agonist (IC50=63.8 nM), with improved drug-like properties[1].
|
T13172L1 |
TMP-778
|
1422171-08-1
|
98%
|
|
TMP-778 is a selective inverse agonist of RORγt.
|
T12753 |
RORγt Inverse agonist 6
|
1887161-80-9
|
98%
|
|
RORγt Inverse agonist 6 is an agonist of RORγt inverse. RORγt Inverse agonist 6 can be used in research on Th17-driven autoimmune diseases.
|
T4670 |
SR0987
|
303126-97-8
|
|
|
SR0987 is a RORγt agonist,
|
T4594 |
SR1078
|
1246525-60-9
|
|
|
SR1078 is an agonist of retinoic acid receptor-related orphan receptor (ROR)α/γ.
|
T5164 |
Cabozantinib hydrochloride
|
1817759-42-4
|
97.09%
|
|
Cabozantinib hydrochloride (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt4 (IC50s: 0.035, 1.3, 4.6, 7 and 6 nM...
|
T7388 |
GSK805
|
1426802-50-7
|
98%
|
|
GSK805 is a potent, orally bioavailable retinoid-related orphan receptor gamma t (RORγt) inverse agonist that interacts with the receptor's putative ligand bindi...
|
T13502 |
3-Oxo-5β-cholanoic acid
|
1553-56-6
|
98.01%
|
|
3-Oxo-5β-cholanoic acid (Dehydrolithocholic acid) (Dehydrolithocholic acid) is a bile acid metabolite and inhibits the differentiation of TH17 cells by directly ...
|
T16929 |
SR2211
|
1359164-11-6
|
98.2%
|
|
SR2211 is a specific modulator and an inverse agonist of RORγ(IC50 = 320 nM, Ki = 105 nM).
|
T39250 |
Bevurogant
|
1817773-66-2
|
98.78%
|
|
Bevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases.
|
T13362 |
XY101
|
2349368-16-5
|
98.81%
|
|
XY101 is a selective, metabolically stable and orally available agonist of RORγ inverse(IC50 of 30 nM and a Kd of 380 nM).
|
TQ0007 |
Cintirorgon
|
2055536-64-4
|
98.85%
|
|
Cintirorgon (LYC-55716) is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.
|
T2834 |
Nobiletin
|
478-01-3
|
98.88%
|
|
Nobiletin (Hexamethoxyflavone) is a natural polymethoxylated flavone isolated from citrus peels with anti-inflammatory and anti-tumor activities. Nobiletin is pr...
|
T5163 |
SR1001
|
1335106-03-0
|
99.04%
|
|
SR 1001 is an inverse agonist for RORα/RORγ (Kis: 172/111 nM).
|
T5160 |
SR3335
|
293753-05-6
|
99.41%
|
|
SR3335 (ML 176) is a selective inverse agonist of RORα, competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki: 220 nM).
|
T6690 |
T0901317
|
293754-55-9
|
99.43%
|
|
T0901317 is a potent and selective agonist for both LXR and FXR, with EC50 of ~50 nM and 5 μM, respectively; it inhibits nuclear factor/κB (NF/κB).
|
T3S1251 |
Neoruscogenin
|
17676-33-4
|
99.5%
|
|
1. Neoruscogenin represents a universal pharmacological tool for RORα research due to its specific selectivity profile versus other nuclear receptors.
|
T9635 |
Cedirogant
|
2055496-11-0
|
99.57%
|
|
Cedirogant (ABBV-157) is an orally active retinoid-related orphan receptor-γt(RORγt) inverse agonist that is used for psoriasis study.
|
T37587 |
ML 209
|
1334526-14-5
|
99.65%
|
|
ML-209 is an antagonist of retinoic acid receptor-related orphan receptor γt (RORγt; IC50= 1.1 μM in a reporter assay).1It inhibits RORγt-induced transcription i...
|
T14369 |
AZD-0284
|
2101291-07-8
|
99.75%
|
|
AZD-0284 is an inverse agonist of the nuclear receptor RORγ. In development for the treatment of plaque psoriasis vulgaris and respiratory tract disorders[1].
|